Connect with SHL at Prefilled Syringe Seminar 2017 Tokyo

B News Page740x540

SHL Group is excited to announce that it will exhibit at the Prefilled Syringes Seminar 2017 Tokyo May 23-24, 2017.

During the event, SHL will show a vast range of autoinjectors and pen injectors as well as the latest technologies for high viscosity formulations, such as the Rotaject®.

A dedicated area featuring SHL’s digital solutions to enhance patient adherence will also be available. In connected devices, SHL will showcase Molly® C, a disposable autoinjector with an independent Reading Unit, and FlexRec, a concept technology for smart packaging for multi-medication tracking. Both items can transmit data to the user’s mobile device. SHL will also show the highly-anticipated ENYA Platform, a smart add-on injection tracking offering developed in partnership with Innovation Zed Ltd.

As Japan remains one of the largest markets in Asia for self-administered injection devices, SHL has continued to take part in the annual event so as to connect and share its experiences and learnings with key biopharmaceutical players in the region.

To learn more about our injection devices and digital solutions, visit SHL at the Sola City Conference Center in Tokyo, Japan.

About SHL Medical

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and advanced inhaler and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products.

With locations in Switzerland, Taiwan, Sweden, and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investments in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high-volume and high-viscosity formulations and can be enhanced through digital implementations.

For additional information, visit

Media contact:


Related News